LNTH(Lantheus Holdings, Inc.) · 财务报表

LNTH(Lantheus Holdings, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$425.21M$935.06M$1.30B$1.53B$1.54B
毛利润$187.69M$581.70M$709.54M$988.29M$941.95M
营业利润−$60.83M$36.20M$364.64M$456.98M$310.83M
净利润−$71.28M$28.07M$326.66M$312.44M$233.56M
经营现金流$53.92M$281.78M$305.26M$544.75M$390.14M
自由现金流$53.92M$21.78M$259.92M$493.12M$354.05M
摊薄每股收益$-1.06$0.40$4.65$4.36$3.41

Lantheus Holdings, Inc. LNTH